Resveratrol inhibits LPS-induced apoptosis in VSC4.1 motoneurons through enhancing SIRT1-mediated autophagy

Document Type : Original Article


1 Department of Histology and Embryology, School of Basic Medicine, Jinzhou Medical University, Liaoning 121000, China

2 Department of Orthopedics, First Affiliated Hospital of Jinzhou Medical University, Liaoning 121000, China

3 Medical College of Jinzhou Medical University, Liaoning 121000, China


Objective(s): Resveratrol has been recognized as a potential therapeutic drug in spinal cord injury (SCI). Sirtuin 1 (SIRT1) is vital in the regulation of apoptosis and cell stress response. In this research, our purpose was to explore the mechanisms of resveratrol on neuroprotection and to explore the role of SIRT1.
Materials and Methods: We used lipopolysaccharide (LPS) in the VSC4.1 spinal cord neuron cell line to mimic the micro-environment of the injured spinal cord. The apoptosis of VSC4.1 motoneurons was assessed by TUNEL staining, Western blot, and RT-PCR. Immunofluorescence staining was used to observe the expression site of SIRT1, LC3-B, and Beclin-1, and their protein levels were measured by Western blot and RT-PCR.
Results: Our results showed that resveratrol inhibits LPS-induced apoptosis in VSC4.1 motoneurons. Levels of LC3-B, beclin-1, and SIRT1 indicated a significant increase after resveratrol treatment. But, if autophagy was inhibited, apoptosis in VSC4.1 motoneurons significantly increased. When the cells were treated with EX527, a SIRT1 inhibitor, the protein contents of LC3-B and Beclin-1 were suppressed.
Conclusion: Resveratrol inhibits apoptosis through promoting autophagy in VSC4.1 motoneurons. SIRT1 was involved in autophagy activated by resveratrol in VSC4.1 motoneurons.


1. Zhaohui C, Shuihua W. Protective Effects of SIRT6 against inflammation, oxidative stress, and cell apoptosis in spinal cord injury. Inflammation 2020; 5: 1751-1758.
2. Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 1997; 3: 73-76.
3. Wei HY, Ma X. Tamoxifen reduces infiltration of inflammatory cells, apoptosis and inhibits IKK/NF-kB pathway after spinal cord injury in rats. Neurol Sci 2014; 11: 1763-1768.
4. Zhang Q, Xiong Y, Li B, Deng GY, Fu WW, Cao BC, et al. Total flavonoids of hawthorn leaves promote motor function recovery via inhibition of apoptosis after spinal cord injury. Neural Regen Res 2021; 2: 350-356.
5. Wu C, Xu H, Li J, Hu X, Wang X, Huang Y, et al. Baicalein Attenuates pyroptosis and endoplasmic reticulum stress following spinal cord ischemia-reperfusion injury via autophagy enhancement. Front Pharmacol 2020; 11: eCollection.
6. Guo H, He Y, Bu C, Peng Z. Antitumor and apoptotic effects of 5-methoxypsoralen in U87MG human glioma cells and its effect on cell cycle, autophagy and PI3K/Akt signaling pathway. Arch Med Sci 2019; 6: 1530-1538.
7. Zhou K, Zheng Z, Li Y, Han W, Zhang J, Mao Y, et al. TFE3, a potential therapeutic target for spinal cord injury via augmenting autophagy flux and alleviating ER stress. Theranostics 2020; 20: 9280-9302.
8. Luo F, Sandhu AF, Rungratanawanich W, Williams GE, Akbar M, Zhou S, et al. Melatonin and autophagy in aging-related neurodegenerative diseases. Int J Mol Sci 2020; 19: E7174.
9. Iside C, Scafuro M, Nebbioso A, Altucci L. SIRT1 activation by natural phytochemicals: an overview. Front Pharmacol 2020; eCollection.
10. Xu F, Xu J, Xiong X, Deng Y. Salidroside inhibits MAPK, NF-κB, and STAT3 pathways in psoriasis-associated oxidative stress via SIRT1 activation. Redox Rep 2019; 1: 70-74.
11. Herranz D, Muñoz-Martin M, Cañamero M, Mulero F, Martinez-Pastor B, Fernandez-Capetillo O, et al. Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat Commun 2010; online.
12. Stoyas CA, Bushart DD, Switonski PM, Ward JM, Alaghatta A, Tang MB, et al. Nicotinamide pathway-dependent sirt1 activation restores calcium homeostasis to achieve neuroprotection in spinocerebellar ataxia type 7. Neuron 2020; 4: 630-644.
13. Kreiner G, Sönmez A, Liss B, Parlato R. Integration of the deacetylase SIRT1 in the response to nucleolar stress: metabolic implications for neurodegenerative diseases. Front Mol Neurosci 2019; eCollection.
14. Cattelan A, Ceolotto G, Bova S, Albiero M, Kuppusamy M, De Martin S, et al. Nad+/- dependent sirt1 deactivation has a key role on ischemia–reperfusion-induced apoptosis. Vascul Pharmacol 2015; 70: 35-44.
15. Tian Q, Fan X, Ma J, Han Y, Li D, Jiang S, et al. Resveratrol ameliorates lipopolysaccharide-induced anxiety-like behavior by attenuating YAP-mediated neuro-inflammation and promoting hippocampal autophagy in mice. Toxicol Appl Pharmacol 2020;online.
16. Fei Gao, Zhiqiang Liu, Wei Ren, Wen Jiang. Acute lipopolysaccharide exposure facilitates epileptiform activity via enhanced excitatory synaptic transmission and neuronal excitability in vitro. Neuropsychiatr Dis Treat 2014; 10: 1489–1495.
17. Derek S. Wheeler, John S. Giuliano Jr, Patrick M. Lahni, Alvin Denenberg, Hector R. Wong, Basilia Zingarelli. The immunomodulatory effects of albumin and in vivo. Adv Pharmacol Sci 2011; 2011: 691928.
18. Shahid Husain, Gregory I. Liou, Craig E. Crosson. Opioid receptor activation: suppression of ischemia/reperfusion-induced production of tnf-αin the retina. Invest Ophthalmol Vis Sci 2011; 5: 2577-2583.
19. Svetlana Nikolaeva, Vera Bachteeva, Ekaterina Fock, Sabine Herterich, Elena Lavrova, Alexandra Borodkina, et al. Frog urinary bladder epithelial cells express TLR4 and respond to bacterial LPS by increase of iNOS expression and L-arginine uptake. Am J Physiol Regul Integr Comp Physiol 2012; 303: R1042–R1052.
20. Lir-Wan Fan, Lu-Tai Tien, Baoying Zheng, Yi Pang, Rick C. S. Lin, Kimberly L. Simpson, et al. Dopaminergic neuronal injury in the adult rat brain following neonatal exposure to lipopolysaccharide and the silent neurotoxicity. Brain Behav Immun 2011; 2: 286–297.
21. Chung ES, Chung YC, Bok E, Baik HH, Park ES, Park JY, et al. Fluoxetine prevents LPS-induced degeneration of nigral dopaminergic neurons by inhibiting microglia-mediated oxidative stress. Brain RES 2010; 1363: 143-150.
22. May-Jywan Tsai, Jyh-Fei Liao, Di-You Lin, Ming-Chao Huang, Dann-Ying Liou, Hsin-Chun Yang, et al. Silymarin protects spinal cord and cortical cells against oxidative stress and lipopolysaccharide stimulation. Neurochem Int 2010; 8: 867-875.
23. Myers MJ, Shepherd DL, Durr AJ, Stanton DS, Mohamed JS, Hollander JM, et al. The role of SIRT1 in skeletal muscle function and repair of older mice. J Cachexia Sarcopenia Muscle 2019; 4: 929-949.
24. Mei ZG, Huang YG, Feng ZT, Luo YN, Yang SB, Du LP, et al. Electroacupuncture ameliorates cerebral ischemia/reperfusion injury by suppressing autophagy via the SIRT1-FOXO1 signaling pathway. Aging (Albany NY). 2020; 13: 13187-13205.
25. Rege S D, Geetha T, Griffin G D, Broderick TL, Babu JR. Neuroprotective effects of resveratrol in alzheimer disease pathology. Front Aging Neuro Sci 2014; eCollection.
26. Kumar R, Chaterjee P, Sharma PK, Singh AK, Gupta A, Gill K, et al. Sirtuin1: a promising serum protein marker for early detection of alzheimer disease. PLoS One 2013; 4: e61560.
27. Fang Y, Guo C, Zhang P, Zhao W, Wang S, Xing G, et al. Role of autophagy in methylmercury-induced neurotoxicity in rat primary astrocytes. Arch Toxicol 2016; 2: 333-345.
28. Li M, Lindblad J L, Perez E, Bergmann A, Fan Y. Autophagy-independent function of atg1 for apoptosis-induced compensatory proliferation. BMC Biology 2016; online.
29. Cerri S, Blandini F. Role of Autophagy in Parkinson’s Disease. Curr Med Chem 2019; 20: 3702-3718.
30. Jang W, Kim H J, Li H, Jo KD, Lee MK, Yang HO. The neuroprotective effect of erythropoietin on rotenone-induced neurotoxicity in SH-SY5Y cells through the induction of autophagy. Mol Neurobiol 2016; 6: 1-10.
31. Galluzzi L, Morselli E, Vicencio JM, Kepp O, Joza N, Tajeddine N, et al. Life, death and burial: multifaceted impact of autophagy. Biochem Soc Trans 2008; 36: 786-790.
32. Meng L, Ping G, Zhang J. Crosstalk between autophagy and apoptosis: potential and emerging therapeutic targets for cardiac diseases. Int J Mol Sci 2016; 3: 332.
33. Djavaherimergny M, Maiuri M C, Kroemer G. Cross talk between apoptosis and autophagy by caspase-mediated cleavage of beclin1. Oncogene 2010; 12: 1717-1719.
34. Maiuri M C, Criollo A, Kroemer G. Crosstalk between apoptosis and autophagy within the beclin 1 interactome. EMBO J 2010; 3: 515-516.
35. Goodall M L, Fitzwalter B E, Zahedi S, Wu M, Rodriguez D, Mulcahy-Levy JM, et al. The autophagy machinery controls cell death switching between apoptosis and necroptosis. Dev Cell 2016; 4: 337-349.
36. Jorge A, Taylor T, Agarwal N, Hamilton DK. Current agents and related therapeutic targets for inflammation after acute traumatic spinal cord injury. World Neurosurg 2019; 132:138-147.
37. Ghosh A, Pal R. Spinal cord injury: Point-of-care biomarkers for better prognosis. J Neurosci Rural Pract 2019; 3: 390-391.
38. Mataliotakis G I, Tsirikos AI. Spinal cord trauma: pathophysiology, classification of spinal cord injury syndromes, treatment principles and controversies. Orthopaedics & Trauma 2016; 5: 440-449.
39. Hilton BJ, Moulson AJ, Tetzlaff W. Neuroprotection and secondary damage following spinal cord injury: concepts and methods. Neuroscience Letters 2017; 652: 3-10.
40. Beattie M S, Farooqui AA, Bresnahan J C. Review of current evidence for apoptosis after spinal cord injury. J Neurotrauma 2000; 10: 915-925.
41. Bastianetto S, Ménard C, Quirion R. Neuroprotective action of resveratrol. Biochimica Et Biophysica Acta 2015; 6: 1195-1201.